Argus Investors' Counsel, Inc. Iqvia Holdings Inc. Transaction History

Argus Investors' Counsel, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 30, 2020	SELL	$141.28 - $169.75 $607,221 - $729,585	-4,298 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$100.04 - $153.06 $76,030 - $116,325	760 Added 21.48%	4,298 $610,000
Q1 2020 Apr 24, 2020	BUY	$84.0 - $166.11 $7,392 - $14,617	88 Added 2.55%	3,538 $382,000
Q4 2019 Jan 17, 2020	BUY	$137.59 - $155.95 $35,635 - $40,391	259 Added 8.12%	3,450 $533,000
Q3 2019 Oct 17, 2019	SELL	$148.25 - $161.46 $11,118 - $12,109	-75 Reduced 2.3%	3,191 $477,000
Q2 2019 Jul 10, 2019	BUY	$132.28 - $160.9 $434,804 - $528,878	3,287 Added 101.29%	6,532 $1.05 Million
Q2 2019 Jul 10, 2019	SELL	$132.28 - $160.9 $432,026 - $525,499	-3,266 Reduced 50.0%	3,266 $525,000
Q1 2019 Apr 16, 2019	SELL	$109.96 - $144.45 $8,356 - $10,978	-76 Reduced 2.29%	3,245 $467,000
Q4 2018 Feb 06, 2019	BUY	$105.7 - $130.35 $31,815 - $39,235	301 Added 9.97%	3,321 $386,000
Q3 2018 Oct 16, 2018	BUY	$99.3 - $130.77 $35,648 - $46,946	359 Added 13.49%	3,020 $0
Q2 2018 Jul 19, 2018	BUY	$94.85 - $105.95 $252,395 - $281,932	2,661 New	2,661 $266,000

1,139

142M

828K

951K

Ticker IQV
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 185,740,000
Market Cap $35.5B
Description
IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...

Get notified when there are updates to the investment portfolio of Argus Investors' Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Argus Investors' Counsel, Inc. with notifications on news.